LRQA Notified Body Lloyd’s Register Quality Assurance (LRQA) announced on June 13, 2019, that it will be withdrawing services relating to the Medical Devices Directive (93/42/EEC) (MDD) and the In-Vitro Diagnostic Devices Directive (98/79/EC) (IVDD) as well as its application to become a Netherlands-based EU Notified Body for the new…
The potential threat from a no-deal Brexit and the ongoing general Brexit chaos continues to have a negative impact upon the pharmaceutical industry. The UK was legally due to leave the EU on 12 April 2019 but of course the date for departure was delayed once again to 31 October…
Dutch relocation As previously reported here, at the end of March 2019, the European Medicines Agency (EMA) officially relocated from London to Amsterdam. EMA first moved to a temporary address at the Spark building in the north of Amsterdam while waiting for the completion of its purpose built new premises…
The European Medicines Agency has approved approximately 50 out of 60 applications from drug companies applying for the temporary batch testing exemption. MA holders granted the exemption are provided with additional time to move their batch testing sites for centrally authorised products (CAPs) from the UK to the EU. Instead…